Antihypertensive Medications and Diastolic Dysfunction Progression in an African American Population

Heather M. Prendergast, Samuel Dudley, Michael Brown, Martha Daviglus, John Kane, E. Bradshaw Bunney, Jared Marcucci, Rasheed Sanyaolu

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Background: There have been no studies examining the association between antihypertensive medications and progression of diastolic dysfunction. The purpose of this study is to determine whether there is an association between class of antihypertensive medication and diastolic dysfunction progression in an African American population.

Methods: A retrospective cohort study of African American patients with at least two echocardiograms demonstrating diastolic dysfunction drawn from an echocardiogram database at an academic medical center. The main outcome measures were change in diastolic function grade as a function of time and association with hypertension medication classification.

Results: There were 96 African American patients in the database with 2 or more echocardiograms demonstrating diastolic dysfunction; representing 302 echocardiograms. The mean time between echocardiograms was 2.6 years. The mean age was 64.2 (±10.1) years, 78 % were women, and mean BMI 31.2 (±7.4) kg/m2. The majority of subjects had Grade I diastolic dysfunction at their initial examination [N = 87 (90.6 %)]. Approximately 22.9 % (n = 22) of the study cohort demonstrated diastolic dysfunction progression. In multivariate analysis use of calcium channel blockers (CCB) was protective against diastolic dysfunction progression (OR for CCB users vs. non-users 0.28, 95 % confidence interval, 0.09–0.90, p < 0.05).

Conclusions: These findings suggest that use of calcium channel blockers may have a protective effect against progression of diastolic dysfunction among African American patients. Further studies are required to confirm these findings and identify specific factors that can mediate disease progression among African American individuals with hypertension, who face substantial risk of complications such as diastolic heart failure.

Original languageEnglish (US)
Pages (from-to)269-274
Number of pages6
JournalHigh Blood Pressure and Cardiovascular Prevention
Issue number4
StatePublished - Nov 20 2014

Bibliographical note

Funding Information:
Acknowledgments The project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR000050. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Publisher Copyright:
© 2014, Springer International Publishing Switzerland.


  • African-American
  • Antihypertensive medications
  • Diastolic dysfunction
  • Progression


Dive into the research topics of 'Antihypertensive Medications and Diastolic Dysfunction Progression in an African American Population'. Together they form a unique fingerprint.

Cite this